Citation Information :
Gudivada KK. Targeted Heart Rate Control in Sepsis: A Promising Path or a Double-edged Sword?. Indian J Crit Care Med 2024; 28 (12):1093-1095.
Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study. Lancet Lond Engl 2020;395(10219):200–211. DOI: 10.1016/S0140-6736(19)32989-7.
Berk JL, Hagen JF, Beyer WH, Gerber MJ, Dochat GR. The treatment of endotoxin shock by beta adrenergic blockade. Ann Surg 1969;169(1):74–81. DOI: 10.1097/00000658-196901000-00007.
Domizi R, Calcinaro S, Harris S, Beilstein C, Boerma C, Chiche JD, et al. Relationship between norepinephrine dose, tachycardia and outcome in septic shock: A multicentre evaluation. J Crit Care 2020;57:185–190. DOI: 10.1016/j.jcrc.2020.02.014.
Schmittinger CA, Torgersen C, Luckner G, Schröder DCH, Lorenz I, Dünser MW. Adverse cardiac events during catecholamine vasopressor therapy: A prospective observational study. Intensive Care Med 2012;38(6):950–958. DOI: 10.1007/s00134-012-2531-2.
Annane D, Trabold F, Sharshar T, Jarrin I, Blanc AS, Raphael JC, et al. Inappropriate sympathetic activation at onset of septic shock: A spectral analysis approach. Am J Respir Crit Care Med 1999;160(2):458–465. DOI: 10.1164/ajrccm.160.2.9810073.
Suzuki T, Suzuki Y, Okuda J, Kurazumi T, Suhara T, Ueda T, et al. Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis. J Intensive Care 2017;5:22. DOI: 10.1186/s40560-017-0215-2.
Hasegawa D, Sato R, Prasitlumkum N, Nishida K, Takahashi K, Yatabe T, et al. Effect of ultrashort-acting β-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: A Systematic review and meta-analysis of randomized controlled trials. Chest 2021;159(6):2289–2300. DOI: 10.1016/j.chest.2021.01.009.
Guz D, Buchritz S, Guz A, Ikan A, Babich T, Daitch V, et al. β-blockers, tachycardia, and survival following sepsis: An observational cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am 2021;73(4):e921–e926. DOI: 10.1093/cid/ciab034.
Shaver CM, Chen W, Janz DR, May AK, Darbar D, Bernard GR, et al. Atrial fibrillation is an independent predictor of mortality in critically ill patients. Crit Care Med 2015;43(10):2104–2111. DOI: 10.1097/CCM.0000000000001166.
Leibovici L, Gafter-Gvili A, Paul M, Almanasreh N, Tacconelli E, Andreassen S, et al. Relative tachycardia in patients with sepsis: An independent risk factor for mortality. QJM 2007;100(10):629–634. DOI: 10.1093/qjmed/hcm074.
Magder SA. The ups and downs of heart rate. Crit Care Med 2012;40(1):239–245. DOI: 10.1097/CCM.0b013e318232e50c.
Heliste M, Pettilä V, Berger D, Jakob SM, Wilkman E. Beta-blocker treatment in the critically ill: A systematic review and meta-analysis. Ann Med 54(1):1994–2010. DOI: 10.1080/07853890.2022.2098376.
Singer KE, Collins CE, Flahive JM, Wyman AS, Ayturk MD, Santry HP. Outpatient beta-blockers and survival from sepsis: Results from a national cohort of Medicare beneficiaries. Am J Surg 2017;214(4):577–582. DOI: 10.1016/j.amjsurg.2017.06.007.
Arbabi S, Campion EM, Hemmila MR, Barker M, Dimo M, Ahrns KS, et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma 2007;62(1):56–61; Discussion 61–62. DOI: 10.1097/TA.0b013e31802d972b.
Datta PK, Sathe P, Roy A, Baronia T, Bhattacharjee A, Kundu R. The clinical utility of targeted heart rate control in septic shock: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Indian J Crit Care Med 2024;28(12): 1170–1179.
Atal I, Porcher R, Boutron I, Ravaud P. The statistical significance of meta-analyses is frequently fragile: Definition of a fragility index for meta-analyses. J Clin Epidemiol 2019;111:32–40. DOI: 10.1016/j.jclinepi.2019.03.012.
